Showing results (1671-1680 of 9,903) with videos related to
Sort By:
Pageof 991
Bone Marrow Transplantation|March 7, 2013
Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow TransplantationSimona Iacobelli, Bone Marrow Transplantation|July 2, 2013
Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unitN Lehners, P Schnitzler, S Geis, et al.Bone Marrow Transplantation|July 2, 2013
An update to the HLA Nomenclature Guidelines of the World Marrow Donor Association, 2012W Bochtler, M Maiers, J N A Bakker, et al.Bone Marrow Transplantation|July 9, 2013
Active thrombopoiesis is associated with worse severity and activity of chronic GVHDT Bat, S M Steinberg, R Childs, et al.Bone Marrow Transplantation|December 11, 2012
TLI in refractory chronic GVHDR Devillier, L Castagna, L Gonzague, et al.Bone Marrow Transplantation|December 11, 2012
Management of adult patients older than 40 years refractory to at least one immunosuppressive course: HLA-identical sibling HSCT using fludarabine-based conditioningS Maury, M AljurfBone Marrow Transplantation|May 1, 2012
The EBMT activity survey: 1990-2010J R Passweg, H Baldomero, A Gratwohl, et al.Bone Marrow Transplantation|June 5, 2012
Relative recovery of haematopoietic stem cell products after cryogenic storage of up to 19 yearsL J Fernyhough, V A Buchan, L T McArthur, et al.Bone Marrow Transplantation|May 22, 2012
Personality influences quality-of-life assessments in adult patients after allogeneic hematopoietic SCT: results from a joint evaluation of the prospective German Multicenter Validation Trial and the Fred Hutchinson Cancer Research CenterP Y Herzberg, S J Lee, P Heussner, et al.Bone Marrow Transplantation|May 29, 2012
The significant impact of acute kidney injury on CKD in patients who survived over 10 years after myeloablative allogeneic SCTT Shimoi, M Ando, W Munakata, et al.Pageof 991